Complementary medicine clinic care for people with Parkinson's in London
Official title: Observational Case Series of Patients With Parkinson's Disease (PD) Attending a Complementary Medicine Neuro-degenerative Disease (NDD) Clinic.
Run by St. Mary's University, Twickenham · NCT07207096 · Data updated 2026-11-12
This project will collect routine clinic data and questionnaires to see if complementary therapies help people with Parkinson's who attend a London charitable clinic.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | St. Mary's University, Twickenham Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | September 19, 2025 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | October 3, 2025 |
| Trial ID | NCT07207096 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People with a diagnosis of Parkinson's disease or Parkinsonism who can attend the Feldy Community Centre clinic in London or join remote appointments, and who continue their usual medical care, are eligible.
✕Probably not a fit
People needing acute medical assessment, those with other neurodegenerative diseases, or those without a PD/Parkinsonism diagnosis are not included and are unlikely to benefit from this observational documentation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational case series collects routine clinical data and patient questionnaires from consecutive people with Parkinson's or Parkinsonism who attend a charitable complementary medicine neurodegenerative disease clinic in London. Care is delivered alongside patients' usual medical treatments and may include homeopathy, herbalism, hypnosis, healing, and self-help advice on lifestyle, mindfulness, or diet, with follow-up visits about every three months. There is no experimental intervention or change to standard care beyond routine clinic practice, and remote 1.5-hour consultations via a secure Zoom platform are offered when travel is not possible. The aim is to document patient experiences and outcomes over time to improve understanding of complementary therapy use in Parkinson's disease.
Why it matters
Potential benefit: If successful, the project could give patients and clinicians better information about how complementary therapies are used and whether patients report symptom or quality-of-life changes.
How similar studies have gone: Previous research on complementary therapies in Parkinson's is limited and mixed, with small studies or anecdotal reports but no definitive evidence of benefit for the specific therapies used here.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: A diagnosis of Parkinson's Disease (self-reported), and Parkinsonism from any causes (patients may have co-existing other health conditions) Exclusion Criteria: Patients requiring acute medical assessment and management, (as this is beyond the scope of this clinic service) Patients with any other NDD condition Patients without a diagnosis of PD/Parkinsonism. E.g. those at risk of PD such as through a family history (patients in this category may receive treatment at the clinic but are not included in the Observational Case series.
Where it's running
-
Feldy Community Centre
London, United Kingdom Recruiting
Study contacts
- Study coordinator: Philippa Fibert, PhD
- Email: philippa.fibert@stmarys.ac.uk
- Phone: +44 7543345046
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acute intermittent hypercapnia-based interventions for upper airway and axial control in Parkinsonism
This randomized pilot study tests whether a single session of acute intermittent hypercapnic hypoxia or hypercapnic normoxia can improve upper airway and axial motor function in adults with Parkinsonism.
-
Using saliva and extracellular vesicles to diagnose neurodegenerative diseases
This study is testing a new way to diagnose neurodegenerative diseases like Alzheimer's and Parkinson's by analyzing saliva samples to see if it can help identify these conditions earlier and tailor treatments for patients.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.